Daito Pharmaceutical Co.,Ltd.
4577.T · JPX
5/31/2025 | 5/31/2024 | 5/31/2023 | 5/31/2022 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | ¥2 | ¥3 | ¥4 | ¥4 |
| Short-Term Investments | ¥0 | ¥0 | ¥0 | ¥0 |
| Receivables | ¥20 | ¥15 | ¥18 | ¥16 |
| Inventory | ¥18 | ¥21 | ¥18 | ¥17 |
| Other Curr. Assets | ¥1 | ¥2 | ¥1 | ¥1 |
| Total Curr. Assets | ¥42 | ¥41 | ¥41 | ¥38 |
| Property Plant & Equip (Net) | ¥32 | ¥32 | ¥26 | ¥23 |
| Goodwill | ¥0 | ¥0 | ¥0 | ¥0 |
| Intangibles | ¥1 | ¥0 | ¥0 | ¥0 |
| Long-Term Investments | ¥2 | ¥3 | ¥3 | ¥3 |
| Tax Assets | ¥0 | ¥0 | ¥1 | ¥1 |
| Other NC Assets | ¥1 | ¥0 | ¥0 | -¥0 |
| Total NC Assets | ¥36 | ¥36 | ¥30 | ¥27 |
| Other Assets | ¥0 | ¥0 | ¥0 | ¥0 |
| Total Assets | ¥78 | ¥78 | ¥71 | ¥65 |
| Liabilities | – | – | – | – |
| Payables | ¥8 | ¥9 | ¥4 | ¥4 |
| Short-Term Debt | ¥3 | ¥2 | ¥1 | ¥1 |
| Tax Payable | ¥0 | ¥0 | ¥1 | ¥1 |
| Deferred Revenue | ¥0 | ¥0 | ¥5 | ¥4 |
| Other Curr. Liab. | ¥5 | ¥7 | -¥0 | ¥0 |
| Total Curr. Liab. | ¥17 | ¥19 | ¥15 | ¥14 |
| LT Debt | ¥7 | ¥5 | ¥3 | ¥2 |
| Deferred Rev, NC | ¥0 | ¥0 | ¥1 | ¥1 |
| Deferred Tax Liab, NC | ¥0 | ¥0 | ¥0 | ¥0 |
| Other NC Liab. | ¥0 | ¥1 | ¥0 | ¥0 |
| Total NC Liab. | ¥9 | ¥7 | ¥4 | ¥3 |
| Other Liabilities | ¥0 | ¥0 | ¥0 | ¥0 |
| Cap. Leases | ¥0 | ¥2 | ¥0 | ¥0 |
| Total Liabilities | ¥26 | ¥25 | ¥20 | ¥17 |
| Equity | – | – | – | – |
| Pref Stock | ¥0 | ¥0 | ¥49 | ¥0 |
| Common Stock | ¥7 | ¥7 | ¥7 | ¥7 |
| Retained Earnings | ¥37 | ¥37 | ¥35 | ¥32 |
| AOCI | ¥1 | ¥2 | ¥2 | ¥1 |
| Other Equity | ¥0 | ¥0 | ¥0 | ¥0 |
| Total Equity | ¥52 | ¥52 | ¥51 | ¥47 |
| Supplemental Information | – | – | – | – |
| Minority Interest | ¥0 | ¥0 | ¥0 | ¥0 |
| Total Liab. & Tot. Equity | ¥78 | ¥78 | ¥71 | ¥65 |
| Net Debt | ¥8 | ¥4 | ¥1 | -¥1 |